NYSE:GRDN (USA)
Â
Class A Shares
$
19.79
-0.1 (-0.5%)
12:09 AM EST
New Key Statistics Module, Z-Score and F-Score
NYSE:GRDN Key Ratios
| Market Cap $ M | 1,252.59 |
| Enterprise Value $ M | 1,296.60 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 9.82 |
| Price/Sales | 1.35 |
| Price/Free Cash Flow | 263.87 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 895.00 |
| EPS (TTM) $ | -1.43 |
| Beneish M-Score | -3.81 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 9.10 |
| y-y EBITDA Growth Rate % | -249.20 |
| EV-to-EBIT | -17.91 |
| EV-to-EBITDA | -20.68 |
| PEG | -- |
| Shares Outstanding M | 63.29 |
| Net Margin (%) | -9.77 |
| Operating Margin % | -8.05 |
| Pre-tax Margin (%) | -8.40 |
| Quick Ratio | 0.85 |
| Current Ratio | 1.14 |
| ROA % (ttm) | -28.39 |
| ROE % (ttm) | -151.10 |
| ROIC % (ttm) | -34.04 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.19 |
GRDN Number of Guru Trades
GRDN Volume of Guru Trades
Gurus Latest Trades with NYSE:GRDN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:GRDN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guardian Pharmacy Services Inc Insider Transactions
No Available Data
News about NYSE:GRDN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers